Bay Street News

Mettrum Announces Fourth Quarter and Full Fiscal Year 2016 Financial Results Notification

MarketwiredMarketwire.comMettrum Announces Fourth Quarter and Full Fiscal Year 2016 Financial Results Notification

http://www.marketwire.com Marketwired en Copyright: (C) Marketwired 1 http://www.marketwire.com/rss/marketwire_logo.jpg http://www.marketwire.com

TORONTO, ONTARIO–(Marketwired – June 22, 2016) – Mettrum Health Corp. (“Mettrum” or the “Company“) (TSX VENTURE:MT), a fully integrated provider of cannabis products, is pleased to announce that it will report its fourth quarter and full fiscal year 2016 financial results for the period ended March 31, 2016, on June 29, 2016 after the close of market.

About Mettrum Health Corp.

Mettrum Health Corp. is a Tier 1 Industry Issuer listed on TSX Venture Exchange. Mettrum Ltd., a wholly owned subsidiary of the Company, is a Toronto-based company and a licensed producer of medical cannabis under the MMPR, which came into effect on October 1, 2013. Mettrum received its first license from Health Canada under the MMPR on November 1, 2013 and began production of medical cannabis at its first production facility in Bowmanville, Ontario. Mettrum received its second license from Health Canada under the MMPR on December 11, 2014 for its Mettrum Creemore facility in Clearview, Ontario. Mettrum received its third license from Health Canada under the MMPR on December 17, 2015 for its new 60,000 square foot production and distribution facility in Bowmanville, Ontario. With the Company’s three licenses, Mettrum is a leading producer and vendor of medical cannabis under the MMPR system. In addition, through its wholly owned subsidiary Mettrum Hempworks, Mettrum also is a licensed producer and distribution of industrial cannabis (hemp) products, including Mettrum’s functional food line, Mettrum Originals, under the Industrial Hemp Regulations (Canada) issued pursuant to the Controlled Drugs and Substances Act (Canada). For more information, visit: www.mettrumoriginals.com and www.mettrum.com.

Neither the Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Exchange) accepts responsibility for the adequacy or accuracy of this Press release.

]]>
Mettrum Health Corp.
Ali Mahdavi
Director, Investor Relations
416.962.3300
amahdavi@mettrum.com
www.mettrumoriginals.com / www.mettrum.com
]]>
Wed, 22 Jun 2016 12:00:00 GMT